Package Leaflet: Information for the User
Protopic 0.1% Ointment
tacrolimus monohydrate
Read the package leaflet carefully before you start using the medicine, because it contains important information for you.
Contents of thepackage leaflet
The active substance of Protopic, tacrolimus monohydrate, is an immunomodulating agent.
Protopic 0.1% ointment is used to treat moderate to severe atopic dermatitis (eczema) in adults who do not respond adequately to or are intolerant of conventional therapies such as topical corticosteroids.
Once the moderate to severe atopic dermatitis has disappeared or almost disappeared after up to 6 weeks of treatment for a flare, and if you suffer from frequent flares (i.e. 4 or more per year), you can prevent flares from coming back or prolong the time you are free of flares by using Protopic 0.1% ointment twice a week.
In atopic dermatitis, the skin's immune system overreacts, causing skin inflammation (itching, redness, dryness). Protopic modifies the abnormal immune response and relieves skin inflammation and itching.
Do not use Protopic
Warnings and precautions
Talk to your doctor before you start using Protopic:
Children
Other medicines, cosmetics, and Protopic
Tell your doctor or pharmacist if you are using or have recently used or might use any other medicines.
You can use moisturizing creams and lotions during treatment with Protopic, but not in the 2 hours before and after applying Protopic.
The use of Protopic at the same time as other skin preparations or simultaneously with oral corticosteroids (e.g. cortisone) or immunosuppressants has not been studied.
Using Protopic with alcohol
While using Protopic, drinking alcohol may cause flushing or redness of the skin or face and a feeling of warmth.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Protopic contains butylhydroxytoluene (E321)
Protopic contains butylhydroxytoluene (E321), which may cause local skin reactions (such as contact dermatitis) or irritation of the eyes and mucous membranes.
Follow the instructions for administration of this medicine exactly as told by your doctor. If you are not sure, talk to your doctor or pharmacist again.
Adults (16 years of age and older)
Two concentrations of Protopic (Protopic 0.03% and Protopic 0.1% ointment) are available for adult patients (16 years of age and older). Your doctor will decide which concentration is most suitable for you.
Treatment is usually started with Protopic 0.1% ointment, applied twice daily, in the morning and at night, until the eczema has cleared. Your doctor will decide if the frequency of application can be reduced depending on the response of your eczema, or if the lower concentration ointment Protopic 0.03% can be applied.
Treat each affected area of your skin until the eczema has cleared. Improvement is usually seen within one week. If you do not see any improvement after two weeks, talk to your doctor about other possible treatments.
Your doctor may tell you to use Protopic 0.1% ointment twice a week once your atopic dermatitis has cleared or almost cleared. Protopic 0.1% ointment should be applied once daily, twice a week (e.g. Monday and Thursday), to the areas of your body that are usually affected by atopic dermatitis. There should be 2-3 days without treatment with Protopic between applications.
If the symptoms come back, you should use Protopic twice daily, as described above, and go see your doctor to review your treatment.
If you accidentally swallow some ointment
If someone accidentally swallows the ointment, talk to your doctor or pharmacist as soon as possible. Do not try to induce vomiting.
If you forget to use Protopic
If you forget to apply the ointment at the right time, do so as soon as you remember, and then continue as before.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common (may affect more than 1 in 10 people):
These symptoms are usually mild or moderate and generally disappear within one week of using Protopic.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
After twice-weekly treatment, infections at the application site have been reported in adults.
Rosacea (facial redness), rosacea-like dermatitis, lentigo (flat brown spots on the skin), edema at the application site, and herpes infections in the eyes have also been reported during post-marketing use.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging and carton after EXP. The expiry date is the last day of the month shown.
Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Protopic
One gram of Protopic 0.1% ointment contains 1.0 mg of tacrolimus (as tacrolimus monohydrate).
Appearance and packaging of the product
Protopic is a white or slightly yellowish ointment. It is available in tubes containing 10, 30, or 60 grams of ointment. Not all pack sizes may be marketed. Protopic is available in two concentrations (Protopic 0.03% and Protopic 0.1% ointment).
Marketing authorisation holder
LEO Pharma A/S
Industriparken 55
2750 Ballerup
Denmark
Manufacturer
Astellas Ireland Co. Ltd.
Killorglin
County Kerry
Ireland
LEO Laboratories Ltd.
285 Cashel Road
Crumlin, Dublin 12
Ireland
You can get more information about this medicine by contacting the local representative of the marketing authorisation holder:
Belgium LEO Pharma N.V./S.A. Tel: +32 3 740 7868 | Lithuania Biocodex UAB Tel: +370 37 408 681 |
Bulgaria Borola Ltd. Tel: +359 2 9156 136 | Luxembourg LEO Pharma N.V./S.A. Tel: +32 3 740 7868 |
Czech Republic LEO Pharma s.r.o. Tel: +420 225 992 272 | Hungary LEO Pharma Tel: +36 1 888 0525 |
Denmark LEO Pharma AB Tel: +45 70 22 49 11 | Malta E.J. Busuttil Ltd. Tel: +356 2144 7184 |
Germany LEO Pharma GmbH Tel: +49 6102 2010 | Netherlands LEO Pharma B.V. Tel: +31 205104141 |
Estonia Biocodex OÜ Tel: +372 6 056 014 | Norway LEO Pharma AS Tel: +47 22514900 |
Greece LEO Pharmaceutical Hellas S.A. Tel: +30 210 68 34322 | Austria LEO Pharma GmbH Tel: +43 1 503 6979 |
Spain Laboratorios LEO Pharma, S.A. Tel: +34 93 221 3366 | Poland LEO Pharma Sp. z o.o. Tel: +48 22 244 18 40 |
France Laboratoires LEO SA Tel: +33 1 3014 40 00 | Portugal LEO Farmacêuticos Lda. Tel: +351 21 711 0760 |
Croatia Remedia d.o.o. Tel: +385 1 3778 770 | Romania LEO Pharma A/S România Tel: +40 213121963 |
Ireland LEO Laboratories Ltd. Tel: +353 1 490 8924 | Slovenia PHARMAGAN d.o.o. Tel: +386 4 2366 700 |
Iceland Vistor hf. Tel: +354 535 7000 | Slovakia LEO Pharma s.r.o. Tel: +421 2 5939 6236 |
Italy LEO Pharma S.p.A. Tel: +39 06 52625500 | Finland LEO Pharma Oy Tel: +358 20 721 8440 |
Cyprus The Star Medicines Importers Co. Ltd. Tel: +357 2537 1056 | Sweden LEO Pharma AB Tel: +46 40 3522 00 |
Latvia Biocodex SIA Tel: +371 6761 9365 | United Kingdom LEO Laboratories Ltd. Tel: +44 1844 347333 |
Date of last revision of this package leaflet:
Detailed information on this medicine is available on the European Medicines Agency website http://www.ema.europa.eu.
The average price of PROTOPIC 0.1% OINTMENT in October, 2025 is around 23.37 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.